Clinical assessment in juvenile idiopathic inflammatory myopathies and the development of disease activity and damage tools

Current Opinion in Rheumatology

Volumn 16, Issue 6, 2004, Pages 673-677

  Pilkington, Clarissa ^a,b  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Disease activity; Disease damage; Inflammatory myopathies; Juvenile dermatomyositis

Indexed keywords

ACCURACY; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL PRACTICE; CORRELATION ANALYSIS; DERMATOMYOSITIS; DISEASE ACTIVITY; ELECTROMYOGRAPHY; EPIDEMIOLOGICAL DATA; HUMAN; IDIOPATHIC INFLAMMATORY MYOPATHY; INCIDENCE; JUVENILE DERMATOMYOSITIS; LABORATORY TEST; LUNG DISEASE; MUSCLE BIOPSY; MUSCLE STRENGTH; MYOSITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVER VARIATION; ONSET AGE; PHYSICAL DISABILITY; PRIORITY JOURNAL; PROGNOSIS; QUESTIONNAIRE; RELIABILITY; REVIEW; STANDARDIZATION; TREATMENT OUTCOME; VALIDATION PROCESS; VISUAL ANALOG SCALE;

CHILD; HUMANS; MYOSITIS; SEVERITY OF ILLNESS INDEX;

EID: 7044233676     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.bor.0000144039.46906.18     Document Type: Review

References (29)

1. Mendez EP, Lipton R, Ramsey-Goldman R, et al.: US incidence of juvenile dermatomyositis, 1995-1998: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Registry. Arthritis Rheum 2003, 49:300-305.
2. Cassidy JT, Petty RE: Juvenile dermatomyositis. In Textbook of Pediatric Rheumatology, 4th ed. Edited by Cassidy JT, Petty RE. London: WB Saunders, 2001.
3. Bitnum S, Daeschner CW Jr, Travis LB, et al.: Dermatomyositis. J Pediatr 1964, 64:101-131.
4. Spencer CH, Hanson V, Singsen BH, et al.: Course of treated juvenile dermatomyositis. J Pediatr 1984, 105:399-408.
5. Fisler RE, Liang MG, Fuhlbrigge RC, et al.: Aggressive management of juvenile dermatomyositis results in improved outcome and decreased incidence of calcinosis. J Am Acad Dermatol 2002, 47:505-511.
6. Oddis CV, Conte CG, Steen VD, et al.: Incidence of polymyositis- dermatomyositis: a 20-year study of hospital diagnosed cases in Allegheny County, PA 1963-1982. J Rheumatol 1990, 17:1329-1334.
7. Symmons DP, Sills JA, Davis SM: The incidence of juvenile dermatomyositis: results from a nation-wide study. Br J Rheumatol 1995, 34:732-736.
8. Bohan A, Peter JB: Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975, 292:344-347.
9. Rider LG: Assessment of disease activity and its sequelae in children and adults with myositis. Curr Opin Rheumatol 1996, 8:495-506.
10. Santmyire-Rosenberger B, Dugan EM: Skin involvement in dermatomyositis. Curr Opin Rheumatol 2003, 15:714-722.
11. Riley P, Maillard SM, Wedderburn LR, et al.: Intravenous cyclophosphamide pulse therapy in juvenile dermatomyositis. A review of efficacy and safety. Rheumatology Oxford) 2004, 43:491-496.
12. Dolezalova P, Young SP, Bacon PA, et al.: Nailfold capillary microscopy in healthy children and in childhood rheumatic diseases: a prospective single blind observational study. Ann Rheum Dis 2003, 62:444-449.
13. Kobayashi I, Yamada M, Takahashi Y, et al.: Interstitial lung disease associated with juvenile dermatomyositis: clinical features and efficacy of cyclosporin A. Rheumatology Oxford) 2003, 42:371-374.
14. Kimball AB, Summers RM, Turner M, et al.: Magnetic resonance imaging detection of occult skin and subcutaneous abnormalities in juvenile dermatomyositis: implications for diagnosis and therapy. Arthritis Rheum 2000, 43:1866-1873.
15. Maillard SM, Jones R, Owens C, et al.: Quantitative assessment of MRI T2 relaxation time of thigh muscles in juvenile dermatomyositis. Rheumatology 2004, 43:603-608.
16. Civatte M, Schleinitz N, Krammer P, et al.: Class I MHC detection as a diagnostic tool in non-informative muscle biopsies of patients suffering from dermatomyositis. Neuropathol Appl Neurobiol 2003, 29:546-552.
17. Li CK, Varsani H, Holton JL, et al.: MHC class I overexpression on muscles in early juvenile dermatomyositis. J Rheumatol 2004, 31:605-609.
18. Feldman BM, Ayling-Campos A, Luy L, et al.: Measuring disability in juvenile dermatomyositis: validity of the childhood health assessment questionnaire. J Rheumatol 1995, 22:326-331.
19. Singh G, Athreya BH, Fries JF, et al.: Measurement of health status in children with juvenile rheumatoid arthritis. Arthritis Rheum 1994, 37:1761-1769.
20. Lovell DJ, Lindsley CB, Rennebohm RM, et al.: Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. II. The Childhood Myositis Assessment Scale (CMAS): a quantitative tool for the evaluation of muscle function. The Juvenile Dermatomyositis Disease Activity Collaborative Study Group. Arthritis Rheum 1999, 42:2213-2219.
21. Lovell DJ, Giannini EH, Rider L, et al.: Validation and rater reliability of the childhood myositis assessment scale for the juvenile myositis collaborative study group [abstract]. Arthritis Rheum 1996, 38(suppl):S183.
22. Huber AM, Feldman BM, Rennebohm RM, et al.: Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies. Arthritis Rheum 2004, 50:1595-1603. A good paper on clinical functions of CMAS.
23. Dempster H, Porepa M, Young N, et al.: The clinical meaning of functional outcome scores in children with juvenile arthritis. Arthritis Rheum 2001, 44:1768-1774.
24. Bode RK, Klein-Gitelman MS, Miller ML, et al.: Disease activity score for children with juvenile dermatomyositis: reliability and validity evidence. Arthritis Rheum 2003, 49:7-15.
25. Isenberg DA, Allen E, Farewell V, et al.: International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease. Rheumatology Oxford) 2004, 43:49-54.
26. Pilkington C, Murray KJ, Isenberg D: Development of disease activity and damage indices for myositls-initial testing of 4 tools in juvenile dermatomyositis [abstract]. Arthritis Rheum 2001, 44:S294.
27. Ruperto N, Ravelli A, Murray KJ, et al. for the Paediatric Rheumatology International Trials Organisation (PRINTO) Pediatric Rheumatology Collaborative Study Group: Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis. Rheumatology (Oxford) 2003, 42:1452-1659.
28. Rider LG, Miller FW: Classification and treatment of the juvenile idiopathic inflammatory myopathies. Rheum Dis Clin North Am 1997, 23:619-655.
29. Wedderburn LR, Li CK: Paediatric idiopathic inflammatory muscle disease. Best Pract Res Clin Rheumatol 2004, 18:345-358. A good review of JDM.